Health

U.S. FDA approves landmark pancreatic cancer drug that’s shown to improve survival

CTV News 26 Aug

Canada

U.S. FDA approves landmark pancreatic cancer drug that’s shown to improve survival — Sources: CTV News

Patients taking the drug nearly doubled their survival time, with fewer severe side effects, in a study that randomly assigned them to receive the experimental treatment or more chemotherapy.

See all — CTV News →

Aggregated from the leading newsrooms of the country. Every story links to its original source.

Health

See all →

As Congo Ebola deaths pass 3,000, officials seek to track spread via mobile data

CBC · 8 h

Vaccine-preventable illnesses on the horizon again as Canadian kids head back to school

CBC · 17 h

Peel, York regions confirm first human cases of West Nile virus this year

CTV News · 26 h

Hormone replacement therapy claims increase by 228 per cent in five years: Manulife

CTV News · 27 h

Clinical trial patient says ketamine treatment for bipolar depression changed his life

CTV News · 28 h

This U.K. Olympian battled porn addiction for years. He now wants to help others suffering in silence

CTV News · 29 h

Genetic discovery may lead to treatments for OCD and tics

CTV News · 30 h

Doctors, liver specialist team up to better fight hepatitis in Alberta

CBC · 31 h